Researchers have developed an AI stethoscope that discovers heart conditions in 15 seconds, giving NHS GPs a quick and simple tool to spot problems earlier.
A major £40 million investment will drive pioneering research at the University of Edinburgh, aiming to transform diagnosis and treatment for conditions such as autism, fragile X syndrome, and ADHD.
New research shows that exposure to PFAS chemicals may increase the risk of type 2 diabetes by disrupting metabolism and affecting blood sugar regulation.
The UK Government has unveiled an enhanced support plan for people with ME/CFS, including NHS staff training, public awareness campaigns, and up to £200,000 in grants per research project.
The University of Liverpool is leading a £2.7 million clinical trial to investigate vagus nerve stimulation as a treatment for people with drug-resistant epilepsy.
A University of Bristol study finds trained detection dogs can identify Parkinson's disease with up to 98% accuracy by smelling skin swabs, offering promise for early, non-invasive diagnosis.
A new University of Manchester study finds that analysing skin sebum via non-invasive swabs can identify Parkinson's biomarkers up to seven years before motor symptoms emerge, offering hope for earlier detection and intervention.
A University of South Australia team has developed a weekly biodegradable injection of levodopa and carbidopa, offering seven-day release to ease dosing and boost adherence for Parkinson’s patients.
A first-in-patient trial using AAV-based OTOF gene therapy, led by Karolinska Institutet and Chinese hospitals, restored hearing (improving from 106 dB to 52 dB) in 10 individuals aged 1–24.
A new global study reveals that people diagnosed with dementia are living longer than before, thanks to earlier diagnosis and advancements in care that reduce the risk of death post-diagnosis.
